Back to Search
JOHN LANGSTON, PHARM.D
PHARM.D
Pharmacist
NPI: 1508117375Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
4793(ND)
Research & Publications (20)
The neurophysiology and effect of deep brain stimulation in a patient with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism.
PMID 19099380·J Neurosurg·2009
5-case
Synchronous urethral stricture reconstruction via 1-stage ascending approach: rationale and results.
PMID 19296985·J Urol·2009
8-other
Postural instability in Parkinson's disease: the adrenergic hypothesis and the locus coeruleus.
PMID 19210201·Expert Rev Neurother·2009
6-review
Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism.
PMID 19576930·Neurotoxicology·2009
7-preclinical
Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007.
PMID 19165397·Environ Health Perspect·2009
8-other
High throughput automated allele frequency estimation by pyrosequencing.
PMID 18628978·PLoS One·2008
8-other
Genomic investigation of alpha-synuclein multiplication and parkinsonism.
PMID 18571778·Ann Neurol·2008
8-other
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.
PMID 17251522·Neurology·2007
8-other
A proteomics strategy to discover beta-glucosidases from Aspergillus fumigatus with two-dimensional page in-gel activity assay and tandem mass spectrometry.
PMID 18020405·J Proteome Res·2007
8-other
Substrate specificity of streptomyces transglutaminases.
PMID 17625235·Appl Biochem Biotechnol·2007
4-observational
Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter.
PMID 17560790·Neurobiol Dis·2007
7-preclinical
Model fusion, the next phase in developing animal models for Parkinson's disease.
PMID 17449461·Neurotox Res·2007
6-review
Parkin gene variations and parkinsonism: association does not imply causation.
PMID 17262853·Ann Neurol·2007
8-other
Pesticide exposure and self-reported Parkinson's disease in the agricultural health study.
PMID 17116648·Am J Epidemiol·2007
4-observational
Novel features in a patient homozygous for the L347P mutation in the PINK1 gene.
PMID 17055324·Parkinsonism Relat Disord·2007
5-case
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys.
PMID 17960553·Ann Neurol·2007
7-preclinical
The selective kappa-opioid receptor agonist U50,488 reduces L-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates.
PMID 17335811·Exp Neurol·2007
7-preclinical
Chemical genomic profiling for identifying intracellular targets of toxicants producing Parkinson's disease.
PMID 17043098·Toxicol Sci·2007
4-observational
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
PMID 16943538·J Clin Oncol·2006
3-trial
Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates.
PMID 16882311·J Neurochem·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 712 38TH ST NW
FARGO, ND 58102 - Phone
- (701) 893-9220
Quick Facts
- NPI
- 1508117375
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile